Nilsson H
Acta Pharmacol Toxicol (Copenh). 1986;58 Suppl 2:137-49. doi: 10.1111/j.1600-0773.1986.tb02529.x.
The development of new vasoactive drugs has increased the possibilities to treat patients with digital vasospasm, known as Raynaud's phenomenon. The purpose of this paper is to give a review of recent clinical trials and also a short review of the pathophysiological reasons for each type of pharmacological treatment.